Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH 2460751-66-8
Not For Human Use, Lab Use Only.
Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH 2460751-66-8
Bulk purchasing
Send email to vip@kirklandpeptide.com to get VIP discount!
Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA Cas: 2460751-66-8 | 98%+| Kirklandpeptide.,Ltd
Tirzepatide side chain
Product Name | Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA |
---|---|
Cas No | 2460751-66-8 |
Purity | 99.00% |
Properties State | Yellowish |
Molecular Weight | 1224.59 |
Molecular Formula | C66H105N5O16 |
Product Description | Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH is a yellowish medical intermediate in the synthesis of Tirzepatide. Tirzepatide is a dual GIP and GLP-1 receptor agonist and a drug candidate for the treatment of type 2 diabetes. |
IUPAC Name | 2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[2-[2-[2-[[2-[2-[2-[[(4R)-5-[(2-methylpropan-2-yl)oxy]-4-[[20-[(2-methylpropan-2-yl)oxy]-20-oxoicosanoyl]amino]-5-oxopentanoyl]amino]ethoxy]ethoxy]acetyl]amino]ethoxy]ethoxy]acetyl]amino]hexanoic acid |
InChI | InChI=1S/C66H105N5O16/c1-65(2,3)86-61(76)35-22-20-18-16-14-12-10-8-7-9-11-13-15-17-19-21-34-58(73)70-56(63(79)87-66(4,5)6)36-37-57 (72)68-39-41-81-43-46-84-49-60(75)69-40-42-82-44-45-83-48-59(74)67-38-28-27-33-55(62(77)78)71-64(80)85-47-54-52-31-25-23-29-50(52)51 -30-24-26-32-53(51)54/h23-26,29-32,54-56H,7-22,27-28,33-49H2,1-6H3,(H,67,74)(H,68,72)(H,69,75)(H,70,73)(H,71,80)(H,77,78)/t55-,56+/m0/s1 |
InChIKey | YWLOWAZATOAHDO-KKQLDWOFSA-N |
Canonical SMILES | CC(C(C)OC(=O)CCCCCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCCC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3= CC=CC=C13)C(=O)OC(C)(C)C |
Storage Condition | Store at under-20 ℃ |
Categories: Long-Action Peptide Drug Series
Tags: Long-action peptide